As experts in pharmaceutical and biotherapeutics innovation, we support you to develop, prove, optimise and scale-up the next generation of biologic products and processes to increase performance, productivity and flexibility.
Using our state-of-the-art facilities we offer high-throughput process development for a range of biopharmaceuticals including RNA, Proteins, AAV and novel molecules including exosomes. Find out more about our capabilities and recent projects: https://www.uk-cpi.com/capabilities/biologics
20 May 2021
CATCH UP ON DEMAND